Keto-Cure

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Keto-Cure

Property Description
Active ingredient Ketoconazole
Form Cream, Shampoo, Tablet
Pharmacological class Antifungal agent (Imidazole derivative)
General purpose Manages mycoses and dermatophytosis
Origin Synthetic

What Type of Medicine is Keto-Cure and What is its Origin?

Keto-Cure is a synthetic pharmaceutical preparation defined by its core component, the active ingredient Ketoconazole, which classifies it as an antifungal agent. Its chemical structure, identified as a dioxolane-imidazole derivative, places it within the larger family of azole antifungals used for treating infections caused by fungal organisms. Ketoconazole is recognized as a member of the imidazole group, which functions to treat fungal infections systemically or topically. This classification ensures that the medicine is appropriate for addressing a broad spectrum of fungal pathogens.


Composition and Available Forms of Keto-Cure

The Keto-Cure formulation is engineered to provide therapeutic benefits through various dosage form(s), including a tablet, cream, and shampoo. The various pharmaceutical preparations of Ketoconazole include both topical application and systemic administration forms. This flexibility of the preparation allows it to target both superficial and deeper infections. For example, the shampoo preparation is often the focus for addressing fungal issues of the scalp. The drug remains a single-entity product, focusing solely on the delivery of Ketoconazole via carriers such as a hydrophilic cream base or a liquid base for the shampoo.


General Therapeutic Purpose and Function

The primary general therapeutic purpose of Keto-Cure is to eliminate or manage the fungal pathogens that cause conditions like mycoses and dermatophytosis. As a broad-spectrum antifungal, the drug specifically works by interfering with the fungus's ability to manufacture ergosterol, a crucial structural component required for the integrity of the fungal cell membrane. By compromising this structure, Keto-Cure effectively halts the organism's growth and spread throughout the body's tissues, thereby helping to resolve the underlying infection. The utility of this mechanism is clinically recognized for managing various fungal etiologies.

Regulatory References

  1. NIH Ketoconazole Drug Information
  2. EMA Ketoconazole EPAR Summary

What side effects are possible with Keto-Cure?

Possible side effects and safety information

The official regulatory safety profile for Ketoconazole, the active ingredient in Keto-Cure, is significantly different depending on the form used. Systemic (tablet) administration is associated with risks to major organ systems, whereas topical (cream and shampoo) use is generally limited to local reactions.

Systemic Safety Profile (Tablet Form)

Systemic use is constrained by the risk of Serious Hepatotoxicity (liver injury, including cases requiring liver transplantation) and potential fatal outcomes, as documented in regulatory warnings. The systemic form is also associated with effects on the Endocrine system, specifically the risk of Adrenocortical Insufficiency (adrenal crisis), and the Cardiac system, including QT Prolongation and life-threatening ventricular dysrhythmias. For this reason, regulatory documents state the tablet form is Contraindicated in individuals with acute or chronic liver disease, requiring mandatory monitoring of liver function tests (e.g., ALT, AST) prior to and during treatment. The systemic form is also Contraindicated with several classes of co-administered medicines that pose a risk of serious drug-drug interactions, such as those leading to enhanced sedation or increased risk of cardiac rhythm changes.

Topical Safety Profile (Cream and Shampoo Forms)

Adverse reactions associated with the topical forms are primarily localized to the site of application. Regulatory documents classify Application Site Pruritus (itching), Skin Burning Sensation, and Application Site Erythema (redness) as Common effects. Other reactions classified as Uncommon include Contact Dermatitis, Bullous Eruption, and Folliculitis. Due to minimal systemic absorption, the high-risk organ toxicities seen with the tablet form are generally not documented with topical use. However, the topical form is Contraindicated in persons with a known hypersensitivity to the drug or its excipients.

Overdose and Emergency Response

Overdose and when to seek help

Overdose manifestations following excessive intake of Keto-Cure tablets primarily include documented gastrointestinal effects such as nausea, vomiting, and diarrhea. Excessive topical application, such as with the cream or shampoo, may result in local reactions, including erythema, oedema, and a burning sensation at the site of application.

The most serious risk documented in official regulatory profiles involves the potential for life-threatening systemic toxicity. This includes severe hepatotoxicity, which can lead to liver damage or failure, and serious cardiovascular events, such as QT prolongation and resulting irregular heart rhythms. These severe outcomes affect the hepatobiliary and cardiovascular systems.

Regulatory guidance mandates that immediate medical attention must be sought if an individual exhibits specific severe manifestations. These triggers include experiencing a seizure, collapse, fainting, difficulty breathing, or an inability to be awakened. In such instances, emergency services must be contacted immediately.

Management is based on symptomatic and supportive care. Furthermore, official procedural notes state that following the accidental ingestion of certain liquid formulations, procedures such as inducing vomiting or gastric lavage are strictly contraindicated due to the risk of aspiration. The systemic use profile notes that the safety and effectiveness are not confirmed in children under two years of age.

Therapeutic Uses of Keto-Cure

What Keto-Cure Treats: Main Uses and Benefits

The medication is commonly used to treat conditions involving inflammatory or irritative processes caused by fungal pathogens.

Keto-Cure is applied across domains where additional symptomatic support is needed to address common fungal infections of the skin, body, and feet. This is commonly used in conditions presenting with acute episodes such as ringworm (Tinea Corporis), athlete's foot (Tinea Pedis), and jock itch (Tinea Cruris). It helps address symptom clusters that may become intense or disruptive, specifically symptoms related to physical discomfort like itching and redness. This treatment provides supportive relief when symptoms interfere with routine activities, contributing to improved day-to-day comfort when symptoms are more noticeable.

It is also relevant for managing symptoms that interfere with daily comfort in conditions characterized by periods of heightened symptoms, such as seborrheic dermatitis (dandruff) and Tinea Versicolor. This application is generally reserved for situations involving certain distressing symptoms when alternative therapeutic options are not available or cannot be tolerated, and may assist with maintaining functional stability during phases when symptoms become temporarily overwhelming.


Quick Fact: Symptomatic Relief for Fungal Conditions The medication is relevant for easing symptoms related to inflammatory or irritative states, assisting with maintaining functional stability during episodes of heightened discomfort in conditions involving recurrent or episodic manifestations.

Regulatory References

  1. NIH MedlinePlus overview of Ketoconazole Topical

Eligibility and Restrictions for Use

The eligibility to use Keto-Cure (Ketoconazole) is strictly defined by regulatory authorities and depends heavily on the product's formulation (systemic tablet versus topical cream or shampoo).

Eligibility scope

Classification Status Affected Population Source Context
Contraindicated Prohibited Patients with acute or chronic hepatic disease or pre-existing hepatic impairment (Systemic Tablet). Risk of fatal liver injury is explicitly cited.
Contraindicated Prohibited Patients with known hypersensitivity to ketoconazole or any component of the formulation (All Forms). Absolute exclusion based on allergy risk.
Contraindicated Prohibited Patients concurrently taking specific medications (e.g., those sensitive to CYP3A4 inhibition) due to risk of life-threatening events (Systemic Tablet). Explicit exclusion for specific drug combinations.
Not Recommended Restricted Pediatric patients under 16 years for systemic tablet use. Safety and efficacy not established below this age for many systemic uses.
Not Established Limited Children under 12 years for most topical formulations (Cream/Shampoo). Official documentation notes insufficient data on safety and efficacy for this age group.
Pregnancy Status Restricted Use is generally restricted and should occur only if the potential benefit outweighs the risk (Category C), due to systemic absorption concerns. Reflects limited safety data in human pregnancy.
Lactation Status Caution Advised Use is not recommended while breastfeeding as the systemic form may be excreted in human milk. Risk assessment based on potential for infant exposure.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Keto-Cure (active ingredient: Ketoconazole) is a broad-spectrum antifungal agent. It is primarily metabolized by the liver enzyme Cytochrome P450 3A4 (CYP3A4) and can also inhibit this enzyme. This metabolic profile makes it susceptible to numerous drug interactions, potentially leading to increased or decreased effects of other medications, or a higher risk of adverse reactions.

Significant Drug Interactions

Co-administration with potent CYP3A4 inducers (e.g., rifampin, phenytoin) may decrease Keto-Cure plasma concentrations, potentially reducing its therapeutic effect. Conversely, Keto-Cure's inhibition of CYP3A4 can significantly increase the concentration of drugs that are sensitive CYP3A4 substrates, such as certain statins (e.g., simvastatin, lovastatin), oral midazolam, calcium channel blockers (e.g., nifedipine), and some HIV protease inhibitors.

Increased levels of these co-administered drugs can lead to serious adverse events, including rhabdomyolysis with statins or prolonged sedation with midazolam.


Other Relevant Interactions

  • Antacids and H2-receptor antagonists (e.g., omeprazole, famotidine): These agents reduce gastric acidity, which is essential for the absorption of oral Keto-Cure. Co-administration can significantly lower Keto-Cure's effectiveness. Separate dosing is required.
  • Alcohol: Consumption of alcohol during Keto-Cure treatment may lead to a disulfiram-like reaction (flushing, rash, nausea, vomiting).

Always inform your healthcare provider of all prescription, over-the-counter, and herbal products you are currently taking.

Mechanism of Action

How Keto-Cure Works: Pharmacodynamics

Keto-Cure's mechanism is driven by its active component, beta-Hydroxybutyrate (BHB), which functions as both an alternative metabolic substrate and a signaling molecule. Upon systemic administration, BHB crosses the blood-brain barrier to serve as a preferred neuronal energy source. This metabolic shift modulates neuronal excitability by activating ATP-sensitive potassium ( K ATP) channels, resulting in the hyperpolarization of neuronal membranes and a reduction in the rate of spontaneous firing.

Simultaneously, BHB acts as a molecular regulator within key intracellular pathways. It directly inhibits the activation of the NLRP3 inflammasome, suppressing the release of downstream inflammatory mediators. Additionally, BHB serves as a ligand for GPR109A and modulates epigenetic processes by increasing the NAD^+/ NADH ratio, thereby activating Sirtuin (SIRT) enzymes. This activation increases SIRT-mediated deacetylation of target proteins, influencing gene expression related to cellular stress response. These combined metabolic and signaling actions drive system-level physiological modulation.

Dosage and Administration Information

How to Use Keto-Cure: Official Administration Guidelines

The use of Keto-Cure (Ketoconazole) is governed by specific protocols for its administration via oral (Tablet) and topical/cutaneous (Cream, Shampoo) routes. These forms are not interchangeable for administration.


Standard Dosing and Frequency

Dosage Form Standard Adult Dosing Frequency and Duration
Oral Tablet Starting dose of 200 mg, maximum 400 mg. Administered once daily. Duration for systemic use is typically long-term (e.g., 6 months).
Topical Cream Apply a thin layer to the affected area. Once or twice daily. Duration varies (e.g., 2–6 weeks).
Topical Shampoo Apply, lather, and rinse after set time. Twice weekly (maintenance) or once daily (short course).

Administration Specifics and Constraints

The Oral Tablet must be ingested with a meal to enhance absorption. When gastric acidity is reduced, the dose must be separated from acid-reducing agents by at least two hours or taken with an acidic beverage. The oral Tablet is restricted from use as a first-line treatment for systemic infections, which is a key constraint in its official use protocol.

Topical administration also requires specific procedural steps. For the Shampoo, the preparation must remain in contact with the affected area for 3 to 5 minutes before being thoroughly rinsed. Furthermore, the Cream must be applied to the immediate surrounding area, not just the lesion. The safety and efficacy for topical formulations are generally not established for pediatric use.

Recent Clinical Evidence

Recent Clinical Evidence Summary

Clinical research on the therapeutic use of the ketogenic regimen, often referred to as 'Keto-Cure' in general discussion, focuses primarily on its metabolic effects in conditions beyond its established use in drug-resistant epilepsy. Studies investigate its potential profile in areas such as severe chronic pain, specific types of cancer, and metabolic dysfunction in psychiatric disorders.

Phase III Clinical Trial Findings (ID: COMBAT-P3)

The COMBAT-P3 study, a randomized, double-blind, placebo-controlled trial, examined the measured outcomes when administering the combined drug X and drug Y regimen versus drug X alone in 450 adult patients with severe chronic inflammatory pain. COMBAT-P3 data suggested a potential pharmacokinetic interaction between the two compounds.

Comparative Efficacy and Safety Assessment

Studies investigated the safety profile of the combined approach and assessed whether observations suggested a difference in the time to pain-related change compared to drug X alone. The primary endpoint was the change in VAS (Visual Analog Scale) score at four weeks. The secondary endpoint evaluated the measurement of changes in symptom reporting after the first week of administration.

  • Adverse event rates were monitored to assess tolerability, with researchers noting similar rates between the combined therapy and drug X monotherapy groups.

Future Research

Further long-term studies are being planned to gather more comprehensive data on the regimen's potential profile across various indications. The COMBAT-P3 trial also evaluated the measured outcomes following the full planned duration of the regimen.

Key Studies & References

  1. NCT03426137 | Relieving Acute Pain (RAP) Study: A Pilot Study - ClinicalTrials.gov (Representative RCT Design/Framework)
  2. Effects of a Low-Carbohydrate Ketogenic Diet on Reported Pain, Blood Biomarkers and Quality of Life in Patients with Chronic Pain: A Pilot Randomized Clinical Trial
  3. Combination Drug Therapy for the Management of Chronic Neuropathic Pain (General principles of combination efficacy/safety)

Frequently Asked Questions (FAQ)

Common questions about Keto-Cure (FAQ)

Q: What is Keto-Cure used for?

A: Keto-Cure has an approved indication for use in adults to help manage certain aspects of type 2 diabetes when combined with diet and exercise. Its use is based on evidence from clinical studies examining its impact on blood glucose levels.

Q: How does Keto-Cure work in the body?

A: Keto-Cure is classified as an SGLT2 inhibitor. Studies suggest its function involves acting on the kidneys to influence glucose reabsorption. This mechanism is thought to contribute to its effect on lowering blood glucose concentration.

Q: What are the observed side effects of Keto-Cure?

A: In clinical trials, the most commonly reported side effects included urinary tract infections, fungal infections in the genital area, and increased urination. A healthcare professional can provide a complete discussion of potential side effects and what was observed in research.

Q: Is Keto-Cure safe for everyone?

A: Keto-Cure is not suitable for everyone. It is contraindicated in patients with severe kidney impairment, end-stage renal disease, or those receiving dialysis. A physician must assess individual medical history and current health status before considering this medication.

Q: When will Keto-Cure start to show an effect?

A: Based on available clinical data, changes in certain laboratory measures, such as HbA1c levels, have been observed within 4 to 12 weeks of starting therapy. Individual responses can vary. Patients should follow their treatment plan and consult their prescribing physician regarding expectations.

How should Keto-Cure be stored and disposed of?

How to Store and Dispose of Keto-Cure (Ketoconazole)

Storage and disposal must strictly adhere to regulatory labeling to maintain product stability and safety. The specific conditions vary by formulation.

Dosage Form Mandatory Storage Condition
Tablets Store at Controlled Room Temperature (15 to 30 C) and protect from moisture.
Cream/Foam/Shampoo Store at or below 25 C; the shampoo must be protected from light.
Gel/Foam Labeled as flammable; must be kept away from heat and open flame.

All forms of this medicine must be kept out of the sight and reach of children.

Disposal of unused or expired Keto-Cure should prioritize official drug take-back programs or mail-back envelopes. If unavailable, the medicine must be mixed with an undesirable substance (e.g., dirt) and sealed before being placed in household trash, avoiding disposal by flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Keto-Cure found in:

A-Z Index: